66386-22-9

Basic information

• Product Name: 5-(3,4-dimethoxybenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione
• Synonyms: 5-(3,4-dimethoxybenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione;5-[(3,4-dimethoxyphenyl)methylidene]-1,3-diazinane-2,4,6-trione
• CAS NO: 66386-22-9
• Molecular Formula: C₁₃H₁₂N₂O₅
• Molecular Weight: 276.24478
• Mol File: 66386-22-9.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• Density: 1.355g/cm³
• Refractive Index: 1.598
• CAS DataBase Reference: 5-(3,4-dimethoxybenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(3,4-dimethoxybenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione(66386-22-9)
• EPA Substance Registry System: 5-(3,4-dimethoxybenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione(66386-22-9)

Safety Data

• Hazardous Substances Data: 66386-22-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C13H12N2O5/c1-19-9-4-3-7(6-10(9)20-2)5-8-11(16)14-13(18)15-12(8)17/h3-6H,1-2H3,(H2,14,15,16,17,18)

Upstream product

• 67-52-7 BARBITURIC ACID 
• 120-14-9 3,4-dimethoxy-benzaldehyde 

Downstream Products

• 57737-42-5 5-(3,4-dimethoxybenzyl)pyrimidine-2,4,6(1H,3H,5H)-trione 

Relevant articles and documents

A facile single pot synthesis of highly functionalized tricyclic heterocycle compounds via sequential Knoevenagel-Michael addition and their α-glucosidase inhibition, antioxidants and antibacterial studies

A facile methodology was developed which involved multicomponent single pot reaction which yielded the synthesis of highly functionalized tricyclic-heterocycle compounds (1c-6c) and (1d-7d) in good yields (60-80%). The discovered novel methodology involve

Organic synthesis by Twin Screw Extrusion (TSE): Continuous, scalable and solvent-free

Mechanochemistry provides a method to reduce or eliminate the use of solvents by carrying out reactions through the grinding of neat reagents. Until recently a significant drawback of this form of synthesis has been the limited ability to scale up. Howeve

New compounds having skin whitening, antioxidant and PPAR activity, and medical use thereof

PURPOSE: A novel compound with skin whitening, antioxidation, and PPAR activation effects, and a medical use thereof are provided to be used for a pharmaceutical composition or a cosmetic product. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound as an active ingredient. An antioxidative composition for preventing or treating oxidative diseases contains the compound of chemical formula 1 as an active ingredient. The oxidative diseases are selected among skin aging, pigmentation, wrinkling, psoriasis, or eczema. The composition prevents or treats diseases which are regulated by PPAR(peroxisome proliferator-activated receptor) activity. The PPAR includes PPAR alpha or PPAR gamma.